Structural refinement of inhibitors of urea-based soluble epoxide hydrolases

被引:177
作者
Morisseau, C
Goodrow, MH
Newman, JW
Wheelock, CE
Dowdy, DL
Hammock, BD [1 ]
机构
[1] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA
[2] Univ Calif Davis, UCD Canc Ctr, Davis, CA 95616 USA
关键词
epoxide hydrolase; blood pressure; immune response; urea inhibitors; structure-activity relationships; solubility;
D O I
10.1016/S0006-2952(02)00952-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The soluble epoxide hydrolase (sEH) is involved in the metabolism of arachidonic, linoleic, and other fatty acid epoxides, endogenous chemical mediators that play an important role in blood pressure regulation and inflammation. 1,3-Disubstituted ureas, carbamates, and amides are new potent and stable inhibitors of sEH. However, the poor solubility of the lead compounds limits their use. Inhibitor structure-activity relationships were investigated to better define the structural requirements for inhibition and to identify points in the molecular topography that could accept polar groups without diminishing inhibition potency. Results indicate that lipophilicity is an important factor controlling inhibitor potency. Polar groups could be incorporated into one of the alkyl groups without loss of activity if they were placed at a sufficient distance from the urea function. The resulting compounds had a 2-fold higher water solubility. These findings will facilitate the rational design and optimization of sEH inhibitors with better physical properties. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:1599 / 1608
页数:10
相关论文
共 35 条
[1]   Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation [J].
Argiriadi, MA ;
Morisseau, C ;
Goodrow, MH ;
Dowdy, DL ;
Hammock, BD ;
Christianson, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15265-15270
[2]   Detoxification of environmental mutagens and carcinogens: Structure, mechanism, and evolution of liver epoxide hydrolase [J].
Argiriadi, MA ;
Morisseau, C ;
Hammock, BD ;
Christianson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10637-10642
[3]   CDNA CLONING AND EXPRESSION OF A SOLUBLE EPOXIDE HYDROLASE FROM HUMAN LIVER [J].
BEETHAM, JK ;
TIAN, TG ;
HAMMOCK, BD .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 305 (01) :197-201
[4]   IMPROVED RADIOLABELED SUBSTRATES FOR SOLUBLE EPOXIDE HYDROLASE [J].
BORHAN, B ;
MEBRAHTU, T ;
NAZARIAN, S ;
KURTH, MJ ;
HAMMOCK, BD .
ANALYTICAL BIOCHEMISTRY, 1995, 231 (01) :188-200
[5]   New role for epoxyeicosatrienoic acids as anti-inflammatory mediators [J].
Campbell, WB .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (04) :125-127
[6]  
Capdevila JH, 2000, J LIPID RES, V41, P163
[7]   A new class of lipid mediators: cytochrome P450 arachidonate metabolites [J].
Carroll, MA ;
McGiff, JC .
THORAX, 2000, 55 :S13-S16
[8]   THE REACTION OF ARACHIDONIC-ACID EPOXIDES (EPOXYEICOSATRIENOIC ACIDS) WITH A CYTOSOLIC EPOXIDE HYDROLASE [J].
CHACOS, N ;
CAPDEVILA, J ;
FALCK, JR ;
MANNA, S ;
MARTINWIXTROM, C ;
GILL, SS ;
HAMMOCK, BD ;
ESTABROOK, RW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 223 (02) :639-648
[9]   SPECTROPHOTOMETRIC SUBSTRATES FOR CYTOSOLIC EPOXIDE HYDROLASE [J].
DIETZE, EC ;
KUWANO, E ;
HAMMOCK, BD .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (01) :176-187
[10]   GRAPHICAL DETERMINATION OF KM AND KI [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1972, 129 (01) :197-&